Comprehensive assessment of the association between tumor-infiltrating immune cells and the prognosis of renal cell carcinoma

doi:10.5306/wjco.v15.i10.1280

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1510)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

927

Figures (1-4)

Tables (1-3)

Sum=1133

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

130

Download

107

Sum=237

Publishing Process of This Article

Item

Count

Browse

Download

Sum=102

Oct 24, 2024 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Oncol. Oct 24, 2024; 15(10): 1280-1292
Published online Oct 24, 2024. doi: 10.5306/wjco.v15.i10.1280

Full Size Figure Download Figure

Figure 2 Correlation analysis between TNM stage and 22 tumor-infiltrating immune cells in 829 renal cell carcinoma patients. A: Tumor stage and the expression of 22 tumor-infiltrating immune cells (TIICs) in 829 renal cell carcinoma (RCC) patients; B: Node stage and the expression of 22 TIICs in 829 RCC patients; C: Metastasis stage and the expression of 22 TIICs in 829 RCC patients; D: Pathologic stage and the expression of 22 TIICs in 829 RCC patients. NK: Natural killer; M1: Normal activated subset; M2: Alternating-activated subset.

Citation: Wei GH, Wei XY, Fan LY, Zhou WZ, Sun M, Zhu CD. Comprehensive assessment of the association between tumor-infiltrating immune cells and the prognosis of renal cell carcinoma. World J Clin Oncol 2024; 15(10): 1280-1292
URL: https://www.wjgnet.com/2218-4333/full/v15/i10/1280.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i10.1280